Brief: Bioxyne Says March Revenues 147% Up Quarter On Quarter
28/04/2022 02:42
April 28 (Reuters) - Bioxyne:
* MARCH REVENUES 147% UP QUARTER ON QUARTER
Source text for Eikon: ID:nASX4nmjvJ
Further company coverage: BXN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BLS Pharmaceuticals
See all newsBrief: Bioxyne Secures A$50M Exclusive German Supply Agreement With Adrex
Australia's Bioxyne rises to near 8-year high after company secures German supply deal
Australia's Bioxyne at two-week high on supply deal with Remidose LATAM
Brief: Bioxyne Expands LATAM Footprint First Supply Agreement Costa Rica
Australia's Bioxyne hits nearly 8-year high on cannabis firm deal